UBS Gives Mylan (MYL) $32 Target; Applied Dna Sciences (APDN) Sentiment Is 2.67 The FinReviewer
UBS downgraded Mylan (NASDAQ:MYL)’s stock to a Neutral rating from Buy. The ratings change was revealed to investors in a a note today. The firm now has a …